FDA spells out the rules and re­stric­tions for states seek­ing to im­port drugs from Cana­da

The FDA is of­fer­ing more of an ex­pla­na­tion of the guardrails around its pro­gram that may soon al­low states to im­port pre­scrip­tion drugs in some se­lect cir­cum­stances from Cana­da, but on­ly if such im­ports will re­sult in sig­nif­i­cant cost re­duc­tions for con­sumers.

While the agency has yet to sign off on any of the 5 state plans in the works so far, and PhRMA’s suit to block the Trump-era rule al­low­ing such im­ports is stalled, the new Q&A guid­ance spells out the var­i­ous re­stric­tions that states will have to abide by, po­ten­tial­ly sig­nal­ing that a state ap­proval is com­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER